Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large-Cell, Anaplastic

Explore clinical trials studying Lymphoma, Large-Cell, Anaplastic. Study availability and eligibility vary by location and protocol.

289 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Anaplastic trial results

Completed

Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00078949

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +19 more
Locations
  • Rush-Presbyterian-St. Luke's Medical Centre Chicago, Illinois, United States
  • Indiana University Medical Center Indianapolis, Indiana, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • University of Cincinnati, Barrett Cancer Centre Cincinnati, Ohio, United States
View all 27 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma

NCT00003388

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Raritan Bay Medical Center Perth Amboy, New Jersey, United States
  • Albert Einstein Comprehensive Cancer Center The Bronx, New York, United States
View Trial Details
Completed

Bevacizumab and Combination Chemotherapy in Treating Patients With Peripheral T-Cell Lymphoma or Natural Killer Cell Neoplasms

NCT00217425

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations
  • California Cancer Care, Incorporated - Greenbrae Greenbrae, California, United States
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
View all 110 locations
View Trial Details
Completed

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

NCT00585195

Conditions
Advanced Malignancies Except Leukemia, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations
  • University of California, Irvine Medical Center Orange, California, United States
  • University of Colorado Hospital/ Anschutz Cancer Pavilion Aurora, Colorado, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • University of Colorado Aurora, Colorado, United States
View all 29 locations
View Trial Details

Related conditions